Tropomyosin receptor kinase A

Jul 30, 2019

Health Canada approves VITRAKVI® (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion

Jun 26, 2019

HKBU Discovers Mechanisms Underlying Early Life Stress and Irritable Bowel Syndrome

Mar 25, 2019

AlzeCure to Present at International Scientific Conference

Mar 20, 2019

AlzeCure Initiates New Drug Project Within Pain

Nov 27, 2018

Roche launches first IVD pan-TRK immunohistochemistry assay

Oct 22, 2018

SeraCare Announces Launch of Expanded NTRK Reference Material Panel

Dec 20, 2017

Bayer Announces that Loxo Oncology, Inc., Initiates Rolling NDA Submission for Larotrectinib for the Treatment of TRK Fusion Cancers

Dec 12, 2017

Paradigm Diagnostics Announces Fusion Panel Addition to PCDx